Healthcare

Neuren Pharmaceuticals Limited (ASX:NEU) is a biotechnology company focused on developing therapies for neurodevelopmental disorders. The company’s latest announcement relates to a US patent allowance connected with trofinetide, a treatment developed for Rett syndrome, and the potential extension of intellectual property protection associated with …

Emyria Limited (ASX:EMD) is a healthcare company focused on delivering mental health treatment services through its clinic network. The company’s latest update relates to the opening of its first Empax clinic in New South Wales, expanding its treatment footprint and adding further capacity to …

Firebrick Pharma Limited (ASX:FRE) is a pharmaceutical company focused on developing and commercialising nasal health products. The company’s latest update outlines its planned US retail rollout strategy for Nasodine nasal spray and the appointment of a commercial executive to support market development activities.

Memphasys Limited (ASX:MEM) develops fertility technology products, including Felix, a system designed for use in assisted reproductive technology applications. The company’s latest update covers a funding arrangement with Peters Investments, proposed convertible notes and related corporate actions connected with its commercialisation plans.

Chimeric Therapeutics Limited is an ASX-listed oncology company developing cell therapy treatments for cancer. The company's clinical pipeline has centred on CAR-T cell therapy — a technology that engineers a patient's own immune cells to recognise and attack cancer cells. Chimeric'sAssetshave included programmes in …

ReNerve Limited (ASX:RNV) is an Australian medical device company developing technologies for peripheral nerve repair. The company’s lead product, NervAlign, is designed as a nerve cuff device to support nerve repair procedures, while additional products including the Nerve Guide Matrix and Nerve Conduit are …

Echo IQ Limited is an Australian AI and medical technology company developing artificial intelligence-based tools for the diagnosis and management of heart failure using echocardiography. Its flagship product, EchoSolv HF, is designed to analyse echocardiographic data to assist clinicians in identifying and characterising heart …